New study tracks superbug threat in transplant patients
NCT ID NCT07324291
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 22 times
Summary
This study will follow 1,000 adults who have received a stem cell transplant to learn more about a type of drug-resistant bacteria called MBL-CRE. Researchers will check for the bacteria using swabs and track who gets infections, what risk factors are involved, and how the bacteria resist antibiotics. The goal is to better understand and manage this infection risk in transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.